Neuromodulation Market Growth
with Trends, Size and Forecast

The global Neuromodulation Market size is projected to reach a CAGR of 11.2%
from 2023-2030.

Neurological
disorders are defined as disorders that affect the brain as well as the nerves
found throughout the human body and the spinal cord. Acute spinal cord injury,
Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), ataxia, bell's palsy,
brain tumors, cerebral aneurysm, epilepsy, and seizures are some of the common
neurological disorders. The biochemical, structural, or electrical
abnormalities in the brain, spinal cord, or other nerves result in a wide range
of symptoms, such as memory loss, impaired mental ability, lack of
coordination, and persistent or sudden onset of a headache.

Get Free Sample
Report@ https://www.delvens.com/get-free-sample/neuromodulation-market

Neuromodulation technology
utilizes devices that bring about a change in the nervous system either by
stimulation or by modulating brain activity. These are used when the
traditional treatments have failed to evoke the desired response.

Recent Developments

In February 2022, Medtronic (Ireland) received FDA
approval for its InterStim X System, a next-generation personalized sacral
nerve stimulation therapy for bladder and bowel control.

In June 2021, NeuroSigma (US) and KT Corporation (South
Korea) signed a memorandum of understanding for a strategic partnership to
develop and commercialize, inside and outside of Korea, electronic therapies
treating neurological and neuropsychological disorders, including ADHD,
depression, and epilepsy.

Prominent Players

• Abbott


• Aleva


• Neurotherapeutics SA.


• Boston Scientific
  Corporation


• LivaNova


• Medtronic


• MicroTransponder


• Neuronetics


• NeuroPace Inc.


• NeuroSigma


• Nevro Corporation

For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/neuromodulation-market

North America to Dominate the Market

North America garnered the major share in the
neuromodulation market in 2021 and is expected to dominate the global market
during the forecast period.

The growth is due to the rise in the prevalence of
neurological diseases, the presence of key players in the development of
neuromodulation devices, and the well-established infrastructure in the region.

Neuromodulation Market Segmentation:

On the basis of technology

·       
Internal Neuromodulation

·       
External Neuromodulation

On the basis of application

·       
Chronic Pain

·       
Urinary And Fecal Incontinence

·       
Migraine

·       
Failed Back Syndrome

·       
Parkinson Disease

·       
Epilepsy

·       
Tremor

·       
Depression

·       
Other Applications

On the basis of biomaterial

·       
Metallic Biomaterials

·       
Polymeric Biomaterials

·       
Ceramic Biomaterials

Based on region:

·       
Asia Pacific

·       
North America

·       
Europe

·       
South America

·       
Middle East & Africa

The Report helps to identify the opportunities in Global Regions:

·       
North America (the United States, Canada, and
Mexico)

·       
Europe (Germany, UK, France, Italy, Russia,
Turkey, etc.)

·       
Asia-Pacific (China, Japan, Korea, India,
Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))

·       
South America (Brazil etc.)

·       
The Middle East and Africa (North Africa and GCC
Countries)

Get Detailed Report: https://www.delvens.com/report/neuromodulation-market

Frequently Asked Questions

·       
What are the years considered to study
Neuromodulation Market?

·       
What is the compound annual growth rate (CAGR)
of the Neuromodulation Market?

·       
Which region holds the largest market share in
Neuromodulation Market?

·       
Which region is the fastest growing region in
Neuromodulation Market?

·       
Who are the major players in Neuromodulation
Market?

In addition to the market data for Neuromodulation Market, Delvens offers a
client-centric report customized according to the company’s specific demand and
requirement.

More Related Reports:



Occupational
Therapy Software Market 

Respiratory
Syncytial Virus (RSV) Market

About Us:

Delvens is a strategic advisory and
consulting company headquartered in New Delhi, India. The company holds
expertise in providing syndicated research reports, customized research reports
and consulting services. Delvens qualitative and quantitative data is highly
utilized by each level from niche to major markets, serving more than 1K
prominent companies by assuring to provide the information on country, regional
and global business environment. We have a database for more than 45 industries
in more than 115+ major countries globally.

Delvens database assists the
clients by providing in-depth information in crucial business decisions.
Delvens offers significant facts and figures across various industries namely
Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor &
Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food &
Beverages. Our company provides an exhaustive and comprehensive understanding
of the business environment.

Contact us:

Unit No. 01, 3rd Floor, Plot No.
56, Block B

Sector 2 Noida, Near Noida Sector
15 Metro Station 201301, IN

+44 20 3290 6466

+0120- 4903958

sales@delvens.com